| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biochemistry University of Illinois Urbana, Illinois 61801
Estrogen receptor (ER) toxicity has
hampered the development of vertebrate cell lines stably expressing
substantial levels of recombinant wild-type ER. To isolate clonal lines
of HeLa cells stably expressing epitope-tagged ER, we used a
construction encoding a single bicistronic mRNA, in which
FLAG-epitope-tagged human ER
(fER) was translated from a
5'-translation initiation site and fused to the neomycin resistance
gene, which was translated from an internal ribosome entry site. One
stable HeLa-ER-positive cell line (HeLa-ER1) produces 1,300,000
molecules of fER/cell (
20-fold more ER than MCF-7 cells). The HeLa
fER is biologically active in vivo, as judged by rapid
death of the cells in the presence of either 17ß-estradiol or
trans-hydroxytamoxifen and the ability of the cell line to
activate a transfected estrogen response element (ERE)-containing
reporter gene. The FLAG-tagged ER was purified to near homogeneity in a
single step by immunoaffinity chromatography with anti-FLAG monoclonal
antibody. Purified fER exhibited a distribution constant
(KD) for 17ß-estradiol of 0.45
nM. Purified HeLa fER and HeLa fER in crude
nuclear extracts exhibit similar KD values for
the ERE (0.8 nM and 1
nM, respectively), which are approximately 10
times lower than the KD of 10
nM we determined for purified ER expressed
using the baculovirus system. HMG-1 strongly stimulated binding of both
crude and purified HeLa fER to the ERE (KD of
0.25 nM). In transfected HeLa cells, HMG-1
exhibited a dose-dependent stimulation of 17ß-estradiol-dependent
transactivation. At high levels of transfected HMG-1 expression
plasmid, transactivation by ER became partially ligand-independent, and
transactivation by trans-hydroxytamoxifen was increased by
more than 25-fold. These data describe a system in which ER, stably
expressed in HeLa cells and easily purified, exhibits extremely high
affinity for the ERE, and suggest that intracellular levels of HMG-1
may be limiting for ER action.
This article has been cited by other articles:
![]() |
S. C. Roemer, J. Adelman, M. E. A. Churchill, and D. P. Edwards Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding Nucleic Acids Res., June 1, 2008; 36(11): 3655 - 3666. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Fink Neuropeptide Modulators of High Mobility Group Box 1 Secretion as Potential Therapeutic Agents for Severe Sepsis Am. J. Pathol., May 1, 2008; 172(5): 1171 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Curtis, V. S. Likhite, I. X. McLeod, J. R. Yates, and A. M. Nardulli Interaction of the Tumor Metastasis Suppressor Nonmetastatic Protein 23 Homologue H1 and Estrogen Receptor {alpha} Alters Estrogen-Responsive Gene Expression Cancer Res., November 1, 2007; 67(21): 10600 - 10607. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cheng, D. V. Yu, J.-H. Zhou, and D. J. Shapiro Tamoxifen Induction of CCAAT Enhancer-binding Protein {alpha} Is Required for Tamoxifen-induced Apoptosis J. Biol. Chem., October 19, 2007; 282(42): 30535 - 30543. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cheng, C. Zhang, and D. J. Shapiro A Functional Serine 118 Phosphorylation Site in Estrogen Receptor-{alpha} Is Required for Down-Regulation of Gene Expression by 17{beta}-Estradiol and 4-Hydroxytamoxifen Endocrinology, October 1, 2007; 148(10): 4634 - 4641. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wang, C. Zhang, S. K. Nordeen, and D. J. Shapiro In Vitro Fluorescence Anisotropy Analysis of the Interaction of Full-length SRC1a with Estrogen Receptors {alpha} and beta Supports an Active Displacement Model for Coregulator Utilization J. Biol. Chem., February 2, 2007; 282(5): 2765 - 2775. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Roemer, D. C. Donham, L. Sherman, V. H. Pon, D. P. Edwards, and M. E. A. Churchill Structure of the Progesterone Receptor-Deoxyribonucleic Acid Complex: Novel Interactions Required for Binding to Half-Site Response Elements Mol. Endocrinol., December 1, 2006; 20(12): 3042 - 3052. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Eddy, S. Guo, E. G. Demicco, R. Romieu-Mourez, E. Landesman-Bollag, D. C. Seldin, and G. E. Sonenshein Inducible I{kappa}B Kinase/I{kappa}B Kinase {varepsilon} Expression Is Induced by CK2 and Promotes Aberrant Nuclear Factor-{kappa}B Activation in Breast Cancer Cells Cancer Res., December 15, 2005; 65(24): 11375 - 11383. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Das, R. C. Peterson, and W. M. Scovell High Mobility Group B Proteins Facilitate Strong Estrogen Receptor Binding to Classical and Half-Site Estrogen Response Elements and Relax Binding Selectivity Mol. Endocrinol., November 1, 2004; 18(11): 2616 - 2632. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Loven, R. E. Davis, C. D. Curtis, N. Muster, J. R. Yates, and A. M. Nardulli A Novel Estrogen Receptor {alpha}-Associated Protein Alters Receptor-Deoxyribonucleic Acid Interactions and Represses Receptor-Mediated Transcription Mol. Endocrinol., November 1, 2004; 18(11): 2649 - 2659. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. S. Melvin, C. Harrell, J. S. Adelman, W. L. Kraus, M. Churchill, and D. P. Edwards The Role of the C-terminal Extension (CTE) of the Estrogen Receptor {alpha} and {beta} DNA Binding Domain in DNA Binding and Interaction with HMGB J. Biol. Chem., April 9, 2004; 279(15): 14763 - 14771. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Krieg, S. A. Krieg, B. S. Ahn, and D. J. Shapiro Interplay between Estrogen Response Element Sequence and Ligands Controls in Vivo Binding of Estrogen Receptor to Regulated Genes J. Biol. Chem., February 6, 2004; 279(6): 5025 - 5034. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Amir, M. Barua, N. C. McKnight, S. Cheng, X. Yuan, and S. P. Balk A Direct {beta}-Catenin-independent Interaction between Androgen Receptor and T Cell Factor 4 J. Biol. Chem., August 15, 2003; 278(33): 30828 - 30834. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Loven, N. Muster, J. R. Yates, and A. M. Nardulli A Novel Estrogen Receptor {alpha}-Associated Protein, Template-Activating Factor I{beta}, Inhibits Acetylation and Transactivation Mol. Endocrinol., January 1, 2003; 17(1): 67 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Obrero, D. V. Yu, and D. J. Shapiro Estrogen Receptor-dependent and Estrogen Receptor-independent Pathways for Tamoxifen and 4-Hydroxytamoxifen-induced Programmed Cell Death J. Biol. Chem., November 15, 2002; 277(47): 45695 - 45703. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. S. Melvin, S. C. Roemer, M. E. A. Churchill, and D. P. Edwards The C-terminal Extension (CTE) of the Nuclear Hormone Receptor DNA Binding Domain Determines Interactions and Functional Response to the HMGB-1/-2 Co-regulatory Proteins J. Biol. Chem., July 5, 2002; 277(28): 25115 - 25124. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yuan, M. L. Lu, T. Li, and S. P. Balk SRY Interacts with and Negatively Regulates Androgen Receptor Transcriptional Activity J. Biol. Chem., November 30, 2001; 276(49): 46647 - 46654. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. WANG, H. YANG, C. J. CZURA, A. E. SAMA, and K. J. TRACEY HMGB1 as a Late Mediator of Lethal Systemic Inflammation Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1768 - 1773. [Full Text] [PDF] |
||||
![]() |
S. A. Krieg, A. J. Krieg, and D. J. Shapiro A Unique Downstream Estrogen Responsive Unit Mediates Estrogen Induction of Proteinase Inhibitor-9, a Cellular Inhibitor of IL-1{beta}- Converting Enzyme (Caspase 1) Mol. Endocrinol., November 1, 2001; 15(11): 1971 - 1982. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Czura, Haichao Wang, and K. J. Tracey Dual roles for HMGB1: DNA binding and cytokine Innate Immunity, August 1, 2001; 7(4): 315 - 321. [Abstract] [PDF] |
||||
![]() |
S. Oesterreich, P. Zhang, R. L. Guler, X. Sun, E. M. Curran, W. V. Welshons, C. K. Osborne, and A. V. Lee Re-expression of Estrogen Receptor {alpha} in Estrogen Receptor {alpha}-negative MCF-7 Cells Restores both Estrogen and Insulin-like Growth Factor-mediated Signaling and Growth Cancer Res., August 1, 2001; 61(15): 5771 - 5777. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Klinge Estrogen receptor interaction with estrogen response elements Nucleic Acids Res., July 15, 2001; 29(14): 2905 - 2919. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Drew, D. C. Tang, P. E. Berg, and G. P. Rodgers The role of trans-acting factors and DNA-bending in the silencing of human {beta}-globin gene expression Nucleic Acids Res., July 15, 2000; 28(14): 2823 - 2830. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mao and D. J. Shapiro A Histone Deacetylase Inhibitor Potentiates Estrogen Receptor Activation of a Stably Integrated Vitellogenin Promoter in HepG2 Cells Endocrinology, July 1, 2000; 141(7): 2361 - 2369. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Ellwood, Y.-M. Yen, R. C. Johnson, and M. Carey Mechanism for Specificity by HMG-1 in Enhanceosome Assembly Mol. Cell. Biol., June 15, 2000; 20(12): 4359 - 4370. [Abstract] [Full Text] |
||||
![]() |
D. Knutti, A. Kaul, and A. Kralli A Tissue-Specific Coactivator of Steroid Receptors, Identified in a Functional Genetic Screen Mol. Cell. Biol., April 1, 2000; 20(7): 2411 - 2422. [Abstract] [Full Text] |
||||
![]() |
H. Kanamori, S. Krieg, C. Mao, V. A. Di Pippo, S. Wang, D. A. Zajchowski, and D. J. Shapiro Proteinase Inhibitor 9, an Inhibitor of Granzyme B-mediated Apoptosis, Is a Primary Estrogen-inducible Gene in Human Liver Cells J. Biol. Chem., February 25, 2000; 275(8): 5867 - 5873. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Zhang and D. J. Shapiro Activation of the p38 Mitogen-activated Protein Kinase Pathway by Estrogen or by 4-Hydroxytamoxifen Is Coupled to Estrogen Receptor-induced Apoptosis J. Biol. Chem., January 7, 2000; 275(1): 479 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. He, C. H. Liang, and S. J. Lippard Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin PNAS, May 23, 2000; 97(11): 5768 - 5772. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |